Design Therapeutics' GeneTAC platform is revolutionizing genetic disease treatment with small molecules and promising results ...

Drugs targeting amyloid plaques have failed to show efficacy in clinical trials. A new approach is needed to tackle AD ...

Pluristyx has developed a clinical-grade manufacturing process for using a licensed Mad7 gene editing technology to block Human Leukocyte Antigen (HLA) markers expression. Humacyte is optimizing a ...

New gene editing methods have been introduced in the country, bringing new hope to couples who tested positive for certain ...

Research continues in this field of precision oncology and there has been an explosion of novel drugs in this field ...

A team of stem cell scientists have successfully used embryonic stem cell engineering to create a bi-paternal mouse—a mouse ...

Riding recent momentum in the Duchenne muscular dystrophy space, Capricor Therapeutics, Wave Life Sciences, Regenxbio and ...

Scientists at The Hospital for Sick Children (SickKids) have identified a key gene that could lead to next-generation treatments for medulloblastoma, the most common malignant brain tumor in children.

Delve into the increasingly dynamic landscape of ALS treatment development with thirteen companies advancing candidates in ...

Scientists at The Hospital for Sick Children (SickKids) have identified a key gene that could lead to next-generation ...

Researchers find blocking the KCNB2 gene can slow tumour growth, paving the way for next-gen treatments for childhood brain cancer.

Copyright 2025 The Associated Press. All Rights Reserved. People gather around a table of iPhones at an Apple Store in ...